Druckversion

Archiv: Mitteilungen

24.07.2014

HERO Award

Mit dem international ausgeschriebenen „Hero Award“, der von der Firma Novo Nordisk gesponsert wird, sollen Projekte aus den folgenden Bereichen der Hämophilie gefördert werden: → Körperliche Einschränkungen (insbesondere...[mehr]


23.07.2014

Joint European Medicines Agency / European Directorate for the Quality of Medicines and Healthcare workshop on characterisation of new clotting-factor concentrates

European Medicines Agency - News and Events - Joint European Medicines Agency / European...www.ema.europa.euEuropean Union agency responsible for the protection of public and animal health through the scientific evaluation and...[mehr]


22.07.2014

3D Hepatitis C Combo Effective in HIV Patients

3D Hepatitis C Combo Effective in HIV Patientswww.medpagetoday.comMELBOURNE, Australia -- An investigational drug combination for hepatitis C was highly effective in patients who also had HIV, a researcher reported. [mehr]


20.07.2014

Blood Disease Stops Education in Nigeria

Blood Disease Stops Education in Nigeriawww.naij.comChildren with blood diseases in Nigeria go almost entirely undiagnosed and very few go to school. Activists say they are hoping to save lives by raising awareness of hemophilia...[mehr]


17.07.2014

USA: Senators Ask Gilead to Explain Cost of Sovaldi Hepatitis Drug

Senators Ask Gilead to Explain Cost of Sovaldi Hepatitis Drugwww.medscape.comTwo members of the U.S. Senate Finance Committee, including Chairman Ron Wyden, on Friday asked Gilead Sciences Inc to defend the more than $80,000 cost...[mehr]


17.07.2014

Pfizer Announces Positive Top-Line Results From Phase 3 Study Of NONACOG ALFA (BeneFIX®) Once-Weekly Prophylaxis For Hemophilia B

Pfizer Announces Positive Top-Line Results From Phase 3 Study Of NONACOG ALFA (BeneFIX®)...www.pfizer.comOnce-Weekly Prophylaxis Treatment with BeneFIX® Significantly Reduced Annualized Bleeding Rate Compared to On-Demand...[mehr]


17.07.2014

Plant-based Penn research improves hemophilia Treatment

Plant-based Penn research improves hemophilia treatmentwww.upenn.eduHemophilia is a rare but potentially dangerous disease. People with the condition produce very low levels of clotting factor, the proteins in blood that stop...[mehr]


11.07.2014

Biogen prices new, long-acting hemophilia med with eye on patient-switching

Biogen prices new, long-acting hemophilia med with eye on patient-switchingwww.fiercepharmamarketing.comWant to get the latest stories on business strategy, consumer advertising, new drug launches and more sent straight to your...[mehr]


10.07.2014

OPKO's Long-Acting Clotting Factor VIIa-CTP Receives Positive

OPKO's Long-Acting Clotting Factor VIIa-CTP Receives Positive Opinion For Three Orphan Drug...investor.opko.comBroad Designations for Treatment of Hemophilia A & B with Inhibitors As Well As Congenital Factor VII Deficiency...[mehr]


Treffer 1 bis 10 von 963
<< Erste < Vorherige 1-10 11-20 21-30 31-40 41-50 51-60 61-70 Nächste > Letzte >>